Finished, finished!
The United States has just suddenly announced.
First, the U.S. has significantly reduced funding for international scientific research collaboration, a decision that has left global scientific cooperation "deeply hurt." According to statistics, in the past, the U.S. invested over $5 billion annually in international joint research projects, benefiting many cutting-edge studies. For example, in the field of climate research, the U.S. had previously led funding, allowing scientists from multiple countries to collaborate in modeling and exploring countermeasures, resulting in remarkable achievements that improved the global accuracy of predicting climate warming trends by about 30%. Now, with funding drastically cut, many projects have come to a halt, and subsequent critical data updates and deep research advancements have become challenging, putting the global scientific community at risk of collapse.
Second, the U.S. has tightened the issuance of high-tech research talent visas. Recent data shows that in the past, over 100,000 research-related visas were issued annually, attracting global elites to the U.S. to gather wisdom for "brainstorming" and driving breakthroughs in various fields. Now, the quota has been sharply reduced by nearly half, and the process has become several times more complicated, causing many emerging technology studies to be hindered due to a lack of key talent. In the area of fundamental algorithms for artificial intelligence research, the pace of innovation has slowed because outstanding talents from countries like India and China cannot come to the U.S., leading to a backlog of new theories for over six months.
Third, the U.S. has imposed heavy barriers on the sharing of research patents. In the past, patents for international collaboration results were generally shared transparently based on contributions and agreements, promoting technology transfer for commercial use to benefit the public. However, currently, the U.S. restricts over 70% of key patents for use by other countries under the pretext of "national security" and "prioritizing domestic interests," such as the blockade of biopharmaceutical patents, which has hindered the development of generic drugs in other countries, slowing the availability of lifesaving medications and keeping global healthcare costs high.
I feel that these actions by the U.S. are too selfish and self-serving; research knows no borders, and only through joint efforts can we tackle challenges and benefit the world. The current limitations, withdrawal of funding, obstruction of talent, and locking of patents may seem like protecting one’s own "little patch of land" in the short term, but in the long run, they actually destroy the global research ecosystem and hinder the progress of humanity. I sincerely hope that the U.S. can change its course and regain the spirit of cooperation.
To learn more about cryptocurrency and get first-hand cutting-edge information, click on my avatar to follow me. I will share contract trading skills for free, providing daily points.